Concussion Confidence, FDA-Cleared
Oculogica (oculogica.com) scores 73 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Technology brands, Sports & Fitness brands, in the 36th percentile of 19836 Healthcare brands.
Oculogica is a New York City-based healthcare technology company founded in 2013 that develops FDA-cleared eye-tracking devices, EyeBOX® and SNAP™, for objective concussion diagnosis. These tools are designed to assess concussions without relying on patient-reported symptoms, supporting both rapid sideline screening and detailed clinical evaluation. The company's products are aimed at healthcare providers and sports medicine professionals working with patients of all ages, from young athletes to adults.
| Brand Name | Oculogica |
|---|---|
| Domain | oculogica.com |
| Industry | Healthcare, Technology |
| Founded | 2013 |
| Headquarters | New York City |
| Main Competitors | SyncThink, RightEye (72/100), BrainScope (78/100), Sway Medical (78/100), Neurolign (formerly Neuro Kinetics), Abbott (i-STAT TBI) (91/100) |
Moz Domain Authority 37/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Oculogica builds EyeBOX® and SNAP™ - FDA-cleared eye-tracking tools for objective concussion diagnosis and rapid sideline screening." (Meta description: 17 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description, og:image, og:type, Twitter cards. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare.
Social footprint: verified profiles on X (Twitter), LinkedIn, Instagram, YouTube; no detected presence on Facebook, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Oculogica?", Claude could identify the brand as of October 2026. Oculogica is a medical device company that developed EyeBOX, an FDA-cleared, non-invasive eye-tracking device used to help assess concussion and other brain function issues by analyzing eye movements as a patient watches a video. Best known for The EyeBOX eye-tracking device for objective, non-invasive concussion and brain injury assessment.
When asked "Best brands similar to Oculogica?", Claude would recommend Oculogica as of October 2026. It's a notable and relatively unique player in objective neurological diagnostics using eye-tracking technology, so I'd mention it for concussion or brain injury assessment tech questions.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Oculogica's main competitors in Healthcare: RightEye (72/100), BrainScope (78/100), Sway Medical (78/100), Abbott (i-STAT TBI) (91/100).
Sources: Brand Analyzer scan
Oculogica offers two main FDA-cleared products: EyeBOX, an eye-tracking device designed for in-depth clinical diagnosis of concussions, and SNAP, a tool intended for rapid sideline screening of potential concussions. Both products use objective eye-movement measurement rather than relying on patient-reported symptoms, making them applicable across a range of patient ages, from young athletes to adults, in both sports and general clinical settings.
Sources: Oculogica official site
Oculogica is a healthcare technology company based in New York City, founded in 2013, that develops FDA-cleared eye-tracking devices for diagnosing concussions. Its flagship products, EyeBOX® and SNAP™, are designed to provide objective, symptom-independent concussion assessments for patients of all ages, used in both clinical and sideline settings.
Sources: Oculogica official site
Oculogica has limited AI-search visibility, scoring 26/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 22, recommendation 38). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Oculogica official site
Oculogica was founded in 2013. Oculogica operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Oculogica is headquartered in New York City. Oculogica operates in the Healthcare category.
Sources: Wikidata
Oculogica builds and markets FDA-cleared eye-tracking tools-EyeBOX® and SNAP™-that measure eye movement patterns to objectively diagnose concussions. These devices allow clinicians and sports medicine professionals to assess brain function without relying solely on self-reported symptoms, enabling both rapid sideline screening after a potential head injury and more thorough clinical diagnostic evaluation.
Sources: Oculogica official site
Oculogica scores 38/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Oculogica official site
Oculogica is known for developing EyeBOX and SNAP, FDA-cleared eye-tracking devices that provide objective, symptom-independent concussion diagnosis. The company is recognized for applying eye-movement analysis technology to a clinical problem-concussion assessment-that has traditionally depended on subjective patient-reported symptoms, offering an alternative measurable approach usable across age groups and in sideline or clinical environments.
Sources: Oculogica official site
Oculogica can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Oculogica official site
Oculogica's tools are used by healthcare providers, sports medicine professionals, and clinicians who need objective methods to assess concussions in patients ranging from young athletes to adults. These users apply EyeBOX in clinical diagnostic settings and SNAP for rapid sideline screening, such as during sporting events, to determine whether a concussion has occurred without depending solely on self-reported symptoms.
Sources: Oculogica official site
Oculogica scores 26/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Oculogica has a weak AI-visibility profile at 26/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (38/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 37/100 and thin schema.org structured data. In a live check, Claude could already identify Oculogica from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Oculogica: Nuzest (73/100), NuVasive (73/100), Odyssey House of Utah (73/100), Ofa Bamberg (73/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.